ࡱ> 1z|ghijklmnopqrstuvwxyz{|}~t?@ABCDEFc5/  !"#$%&'()*+,-.01234789:;<=G?@ABCDEF6HIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~Root EntrydO)` Current User;SummaryInformation(TDocumentSummaryInformation8,   !"#$%&'()*+,-./01!_㇓ 0KULLANICIKULLANICI՜.+,D՜.+,d    Ekran GsterisifP-- 6ArialLucida Sans Unicode Garamond WingdingsTimes New RomanSymbol Arial BlackVarsaylan TOh+'0pT PXt NASAL SPREY AILAR. KULLANICI2@s:@õGSg  )'    """)))UUUMMMBBB999|PP3f333f3333f3ffffff3f̙3ff333f333333333f33333333f33f3ff3f3f3f3333f33̙33333f333333f3333f3ffffff3f33ff3f3f3f3fff3ffffffffff3ffff̙fff3fffff3fff333f3f3ff3ff33f̙̙3̙ff̙̙̙3f̙3f333f3333f3ffffff3f̙3f3f3f333f3333f3ffffff3f̙3f3ffffffffff!___wwwff4'A x(xKʦ """)))UUUMMMBBB999|PP3f3333f333ff3fffff3f3f̙f3333f3333333333f3333333f3f33ff3f3f3f3333f3333333f3̙33333f333ff3ffffff3f33f3ff3f3f3ffff3fffffffff3fffffff3f̙ffff3ff333f3ff33fff33f3ff̙3f3f3333f333ff3fffff̙̙3̙f̙̙̙3f̙3f3f3333f333ff3fffff3f3f̙3ffffffffff!___www___e_e____eee_e_e_e_eeeeee_e_e_ee_e_e_e_e_e_eeeeeee_ee__e_e_eeeeee_e_e_ee___e_eeeeeeeeee_ee_e_e_e_eeeeee_e_eee__e_eeeee_ee_eeeee_e_eeeeee_e_eeee_ee__eeV}x}x}x}x}x}VxVxVVPV.P.V.POVOVPVOVOV.P(O(((O.POP(!'((VVVxVxe_e}x}}x}}}x}x}V}VPPPOPPVPVVPPPVPP.POP(O(PPV.O!I(PPxVxVOex}x}x}}x}V}VxVVPV.P.O(PPVPVPVPVPVOVPP.POP(((POP((!((VPVPP(P_}}}}}}}x}V}VxPPP.P(POVPVPVPPxPVxVVPVOP(PPVOP("!O.PPPOP(V}x}}}VVxVVPP.O(O(.(O(O.P(POVOPPVPPOP.P.POPOP((!"!((O(((O}x}x}}xVxVVVOP.P.O(P(((O(PPxPVPVPVPVPVOVPVPV.O!I(((P.P(O(}V}xVPPVPVOO(P(O(P(.'(!(.PPPPPOPOP.P.P.P.P(('((OOPOPOP.O}}}xVxVVPVPP(OOP.POO(O(((PPPVPVPVPP.P.P.P(I!I.PPxVPPVPVxVxVVPVPP.P(O(O(O(O(.(('(!('OOVOPOP(O(('((I!!!((PPVOVPVPPPP}}VPVPPOVPP.O(O(P(O(O(I(I!((PPVPVOO(I!(!(!"!I(PVVPVPPVxVPV.PPVPVPP(.(O(((.(('(!(!((POP(O("!(((!!!"(PPVOPPPPVPVPVxVVxVVVxVxVxPV.O(O(O(((I((!I!I(O(O'(!I(VPP(I!IOVVPVPVPPVPOVPV.VVPVVVOVPP(('('((O((((!!!"!(!!!I(OOP(I((!P.POP.PPVOPOVVPVPPVxPVxPVPPP(('((POPOP(O!(!"!"!I(PPPVOO.I(POVPP.PPVOVPPP.P.VVVPPOVPOP'((O.VVOP.O((!"!((OOVPVPVOO(((O(O(O(POVPPxPVOPVxVxVVOVVOP(POx}xVPP(I!"(PPVPVPVP(O(I(I(O(O(POP(PVPP(PPPVOVOVPVPP.O(PV}x}VxPVOO'(!O(PPV.POVOP(O!!'O(O((!((PVPPPOVxOVPVVVOPOPP}}x}x}VPO(O(PPPP.VPVPP(I(POP.VOI!POPVOP.P.VPVOPPPVVV(O(PV}x}VVVVOI(O(PPVPPOVPV(((P(PPVOPO((OPVOVOPPVxVxVxV}PP(P.V}VxPVPxVxOI(POVPxVVPVP(POVV}}P(P.OPOP.P(O.PPPVPVPP("!O(PPPOP.PV}VP'(((OVPVPVPV(((OVxVxxOP(OVOPOPOPOPOVVxVVP(I!"(O(O(POPPxx}OI!I(PPVPPVOO(P.VV}PP.PP(PPVOVOPOPPVOO(O!!!"!((('(.VPVPO'!!I(OOPOP(((((POVV}xVPOPVVxVxPVPP.POP(P(I(P(I(I!('IOVOO((!"!O(O(I(O(I!IOPV}x}x}PVOPVVxPVxPVOO'(((!(.P.O(O'(!(!((('(!(!(!((((O(O!!!I(VV}x}xVPP_____________xx}VVxVxV(('(!(OVVxPO(I("!I(((O(((I(O.VPVOP!"(PPx}}PV(xVVxVVPxPP(O(((P.VVxVPV((!!!((P.P(O(((POVVV(I!P.VV}V}V.(xVxVxPxVVxOO(OOPVVxV}V(O!I(VPPPVOPPV}VP(OOVV}}}}PP(VPVPVPVPVPVV(((OPVxVVPP'(!O.VPVPVPVPV}VV.O(PPxx}}PO((e_e_e_e_e_e_e_e_e_e_e_e_ex}VVVxVVVOP.x}xVxVxVO(I(VVxPxVxVx}x}PPOPPxV}}}VOI(PxVVPPPVVPPOPOxxPVV}VVO('(OVPVVx}VPP.OOVPxVxVVPO'(eeeeeeeeeeeePV}VxVVVxVxPV(P}x}Vx}VV(I(PPVxVx}xPPOI'PPVPVVOP(I(PPOPOVVPVVPVV.P(VVxxVxVV(('('OPPVVVVOO(O'('OOPOP(O'(((_e__e__e__e__e__e__e__e__e__e__e__e__ePPPOVxVxVxVxVVOPOV}}x}VP'I!I(PPVPVPVOPOO(O(((POP(O(I(P(VVPVOPOVVxPVVVVOO(O.VV}}VP(I!!!((O(O(O.P(((O(I(P.P.O'((O((_e_e_e_e_e_e_e_e_e_e_e_e_xVPVOPOxVxVxVxVV(((POVVxVP(O("!I(O(O(I(O(O.POVPx}x}PP(O(O.VVPV.P.O(PPVPVPP(('('((O((((!!!('((('!!"((POVxV}xxx.O!((O_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_exVxVVOVOP.PPVPP(O'I(('O(O(I!"!O(PPV.O!"!"(PPxx}x}}xV(((O(eeeeeeeeeeeeVPVPVOPOP(O(O(((('('I(((O'((((V}VV(I!!!I.VV}x}}x}x.O(O(Oe_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_}VxVxVVPVOP(P(O(P(I(POVPVOP(POxx}}}VP((!"(PP}}}}PP(POP(eeeeeeeeeeeeeeeeeeeeeeeeeVVPVPV.P.O(.(O(((((xVVPV}x}((!"((PVxx}}}PP(O(P.O___e___e___e___e___e___e___e___e___e___e___e___e__}V}xVVVOP.O(POP(O(V}x}}x}x}}}}PO((((!I(VV}x}}P.P.POPOeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeex}VxVPVPV.O(P(POP(OPxV}x}}}x}x}VP((!(((!((VPVVxPP.O(O.P(Pe_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_}}}}VxVxPVOPOPOP.O(V}x}}}xxx(O(I(O(((O(POVOPOP(O.POPOeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee}}VVPVOP(O(O(('O.}x}}x}x}VxO('('O(('(!((O(((O(.(.(O.P_e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e__e_}}}x}V}VPPP.P(O(O(PP}x}x}}x}x}PP(((O(O(O((!((((O(P(P.P.VPeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeex}x}VxVxVPVOP.O(O(((PPx}Vx}VxPO(('O((((((!('((O(..P(O.POP_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e}}x}x}}VPVOP.P(O(OOPV}}}V}VVOP((!I(O(O(I(I(((O(P(POP.PPPeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeex}x}V}xVVPV.P.P(.(O'((PPVPV.O(('(!(!(!(!(!(!(!((O(P(P.P.PP_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e}}}}x}xVxVVOPOP(P(O(O(O(O(O(O((!I((!(!(!I(('I(O(PPVPVOVPVe_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eex}}x}V}VxPVPP(O(O(O(O(('('(!(!(!(!('(!(!(!('('((O(VVV.PPVPV_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e__e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e_e}}}}}}}xVPP.P.O(P.O(O((!I(('I(I'I(('O(I(O(((OOPPxPVPxPVeee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_eee_Pictures9,Wdb,R$.>,b$cut us!TVl ,R$#%UHh8c,b$ 'd5 h, 0AA@8  g4GdGdx: 0ppp@ <4  0TBg4;d;dx: 0(p@ ppʚ;ʚ;<4dddd U 0 r0___PPT10 pp2___PPT9/ 0?  %O  =#,GR0PDE A^I 0LE KORUNMAd 0dGR0P VE KORUNMAd1. Genel nlemler 2. Kemoprofilaksi (0lala korunma) 3. A_1 ile korunmaHdH  .0NFLUENZA-A PANDEM0LER0d( 2BYK 1918-1919 PANDEM0S0d \NEDEN GR0P A^ISI HER YIL YEN0DEN RET0L0YOR ?/d/( NGR0P A^ISI HER YIL YEN0DEN RET0L0YOR ! (d&(<Vnk her y1l salg1n yapan su_lar dei_iyor,0d,0 0NEDEN SU^LAR DE0^0YOR ?d( PEP0DEM0 VE PANDEM0LER0N OLU^UM NEDENLER0)d) P0NSANLA HAYVAN ARASINDA V0RUS ALI^VER0^0)d)( PTRLER ARASINDA 0NFLUENZA V0RUSU GE0^0)d)(OrthomyxoviridaedrAvian Influenza hayvanlarda dei_ik tablolara neden olur.Hayvan1n aktivitesinde azalma,solunum sistemi belirtileri sinir sistemi bulgular1 veya ishal olabilir. Siyanoza neden olabilir.d  PEP0DEM0 VE PANDEM0LER0N OLU^UM NEDENLER0)d)>ANT0JEN0 DE0^0M SH0FT - DR0FT d (.ANT0JEN0K SH0FT OLU^UMU>(  t,http://www.who.int/en/,http://www.who.int/en/Nhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.aspNhttp://www.ntvmsnbc.com/news/131687.asp/ 0DArialBlackmanTTBܖx: 0ܖDLucida Sans UnicodeBܖx: 0ܖ DGaramondns UnicodeBܖx: 0ܖ0DWingdingss UnicodeBܖx: 0ܖ@DTimes New RomanodeBܖx: 0ܖPDSymbolew RomanodeBܖx: 0ܖ`DArial BlackmanodeBܖx: 0ܖ  D .  @n?" d]  @@``   bN]      !" #$Q%&'()*+,-./01345679:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`dR$SGvUpb$xBBedEE+p$$$R$HBrR$5MA4ei!$$$$$$$2$g-GS R$dHe1 +R$DFY37!wi R$SUfN2 R$vZWiS5 b$QDIsA] R$. QY3Q!R$evPYP!R$ذVQ=Er0!R$p(_&v1U1;+!R$Lcq  "b$:bk%rUc/0"R$4qp`i7? _*b$o>#vs!?Hi*b$9-PrSe&!*b$a}:'V7*R$LxquV,^+b$EwwaS?r+R$b;pKs0B +R$i[ZvE p`Դ+$b$|ȿ(BDR +R$niE9<+R$e5Rh+R$u3od Reassortment Yeniden dzenlenme!d!(Influenza virionsdRHEMAGGLUT0N0N VE NRAM0N0DAZLARDA DE0^0M*d*( :HEMAGGLUT0N0N SEKONDER ETK0S0d(PEP0DEM0 VE PANDEM0LER0N OLU^UM NEDENLER0)d) @0NFLUENZA A^ISI SONRASI 0MMUN0TE!d!(0mmunite 10-15 gnde ba_l1yor. Olu_an antikorlar1n koruma sresi 6 hafta- 1 y1l aras1nda dei_iyor.ddd!@Dnya Sal1k rgt ne yap1yor ?!d!(Her y1l salg1na neden olan, influenza su_lar1n1 topluyor. En s1k grlen su_lar1 (Mart-Nisan) belirliyor. Nisan-Austos belirlenen su_lar1n, a_1 retimi iin firmalara verilmesi. Sonuta her y1l a_1 dei_iyor ve yeni a_1 eyll ay1nda uygulamaya haz1r oluyor.d"2A^ININ 00NDE NELER VAR ?d(0naktive influenza virus hemaggltininleri Yumurta proteini, Gentamisin slfat veya neomisin, Thimerosal, Sodyum dezoksikolat.0+dV0d+V#.HANG0 A^I T0PLER0 VAR ?d $RGNCEL KULLANILAN SPL0T A^ILARDAK0 SU^LAR*d*(M A/Moscow/10/99(H3N2) A/New Caledonia/20/99(H1N1) B/Hong Kong/330/2001 0ZGZZN%  &!6A^I NE ZAMAN UYGULANMALI ?d('"(A^ININ UYGULAMA YOLUd(#<A^ININ DOZU VE UYGULAMA SAYISId()$&A^ININ YAN ETK0LER0dEnjeksiyon yerinde ar1 Ate_, Bitkinlik, Ba_-kas ar1s1, Allerjik reaksiyonlar (nadir)X0dX$*%$A^IDA KORUYUCULUK dAntikor yan1t1 10-15 gn sonra olu_ur. 3 haftada pik yapar. Daha nce a_1lananlarda 1. haftada yan1t geli_ir. Sal1kl1 bireylerde %70-90 65 ya_ zerinde %30-70 oran1nda antikor yan1t1 olu_ur..oddRd+&FLKEM0ZDE GR0P A^ISI UYGULAMA ORANI$d$(,'>A^ININ KONTREND0KASYONU VAR MI? d (Yumurta allerjisi olanlar Daha nce grip a_1s1 uygulanmas1 s1ras1nda ciddi allerjik reaksiyonlar1 olanlar Guillan-Barre sendromu olanlar0d$-(\A^I YAPTIRAMAYANLAR KORUNMAK 00N NE YAPMALI ?/d/(Genel nlemler Kemoprofilaksi0d$.)KEMOPROF0LAKS0d/* 0+1,<YEN0 A^I ALI^MALARI VAR MI ?d(NASAL SPREY A^ILAR (Flumist) KORUYUCU MADDES0Z A^ILAR (Fluzone) MUKOZAL A^ILAR d0d0d$0d0d0d0dS2-0NFLUENZA A^ISI KOMPL0KASYONLARI VE HASTALIIN ^0DDET0N0 AZALTMAKTADIRGdG(/45678:;<= > ? @ A BCDEFGHIJKLMNOPQRST U!V"W#X$Y%Z&['\(])^*_+`,a-P! 0` ̙33` ` ff3333f` 333MMM` f` f` 3^?" d_,?nF_ %  %@ %` v?" dd   " @ `@n?" d]  @@``Pf )  )@ )` !) `4p1" dd1 dd0" dd0 dd0dd1" dd1 dd0" dd0 dd0dd   (  ,  Hl_ж_ж a _  * d 6 @ @ @.  H`_ж_ж ` _  * d 6 @ @ @8 } }@ z z  3 @ABB CEF3. ?bb   H   T W6Vw}\gFQ6<1++11 1L b6xQrq 6\}N   - c    0 A Q g     S    6N KawF bFy0 a*ly7lE;uz  B | a F 0 ! 1 < B < & l L 0  @`T   3 j@ABC+EF3. ?==gL6cI}\eA& w6m!W<! &<W!r6W}F6\}>68QNlX^XH8+Sgg||@`Jo 5   3 @AB! CEF3)| ?))\*l{FDNF W% W ! !   ! 6X L b x_ /aF6b}SA$|l\\TT@`T  u>   @AB C%EF3f ?ss&QW}k6D Q r 8 N c t y y ;t Qi gS }8     T   :0\-Q4*%%v*o(V}5q;  S   < s } l \ g} \, L ;n &  Z}\[6 }WF<! e C }h m W ]  ,t B RxkqA,Rg@` {   3 @ABCEF,3 ?,,Lh6\}mWG &a*zCxsh-&jG]~5g6&LLZZ@` u(    3 z@ABCE|F+3 ?__@% M|f4@{ f0`lA}L\A+h MB6ww FJl{ 0V|{J  *5KlGn a*:Pf\|6 /6Kbf|F kP}5x}VvaP@@@` =>    3 @ABlCrEF"3 ?rlrl@`~   Hx_ж_ж Q _  VAna ba_l1k metnini dzenlemek iin t1klay1n, ,.   H_ж_ж `   * d 6 @ @ @  B _ж_ж  _  Anahat metninin biimini dzenlemek iin t1klay1n 0kinci Anahat Dzeyi nc Anahat Dzeyi Drdnc Anahat Dzeyi Be_inci Anahat Dzeyi Alt1nc1 Anahat Dzeyi Yedinci Anahat Dzeyi Sekizinci Anahat Dzeyi Dokuzuncu Anahat Dzeyi2r H  03f޽h ? ̙33 $Varsay1lan Tasar1m 0` ̙33` ` ff3333f` 333MMM` f` f` 3^?" d_,?nF_ %  %@ %` v?" dd   " @ `@n?" d]  @@``Pf )  )@ )` !) `4p1" dd1 dd0" dd0 dd0dd1" dd1 dd0" dd0 dd0dd   (  8 } }@ z z  3 @ABB CEF3. ?bb   H   T W6Vw}\gFQ6<1++11 1L b6xQrq 6\}N   - c    0 A Q g     S    6N KawF bFy0 a*ly7lE;uz  B | a F 0 ! 1 < B < & l L 0  @`T   3 j@ABC+EF3. ?==gL6cI}\eA& w6m!W<! &<W!r6W}F6\}>68QNlX^XH8+Sgg||@`Jo 5   3 @AB! CEF3)| ?))\*l{FDNF W% W ! !   ! 6X L b x_ /aF6b}SA$|l\\TT@`T  u>   @AB C%EF3f ?ss&QW}k6D Q r 8 N c t y y ;t Qi gS }8     T   :0\-Q4*%%v*o(V}5q;  S   < s } l \ g} \, L ;n &  Z}\[6 }WF<! e C }h m W ]  ,t B RxkqA,Rg@` {  3 @ABCEF,3 ?,,Lh6\}mWG &a*zCxsh-&jG]~5g6&LLZZ@` u(   3 z@ABCE|F+3 ?__@% M|f4@{ f0`lA}L\A+h MB6ww FJl{ 0V|{J  *5KlGn a*:Pf\|6 /6Kbf|F kP}5x}VvaP@@@` =>    3 @ABlCrEF"3 ?rlrl@`~   HO_ж_ж F  O VAna ba_l1k metnini dzenlemek iin t1klay1n, ,    HԾO_ж_ж ` _ O |*"l-d    HO_ж_ж a  O *$l-d X    HO_ж_ж c _ O ~*$l-d H  03f޽h ? ̙33 $Varsay1lan Tasar1m 0 0 (     H0c  c 0  B2c  / c 0<  c $޽h ? ̙3380___PPT10./U  0L0 % @z(    Z_ж_ж ? `}   J6 @ @ @   Zc_ж_ж ?   F2 >~> ~ >~^  6A ?T <  c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++n  0L0 % jbP(    ZT5_ж_ж ? `}<$D 0   J6 @ @ @   ZE_ж_ж ?  <$D 0  F2 >~> ~ >~  6A ? S ,$D 0<  c $޽h ? ̙33x___PPT10X.]0G+9D,' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(DN' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-g6B fade*<3<*D' =%(D' =%(DN' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-g6B fade*<3<*D' =%(D' =%(DN' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*5%(D' =-g6B fade*<3<*5D' =%(D' =%(DN' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*5H%(D' =-g6B fade*<3<*5HD' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-o6Bdissolve*<3<*+{'  0L0 %   ` R (  2   fwc_ж_ж$?G C |SARSd 6 @ @ @ 2   f$c_ж_ж$?# C 0NFLUENZA d  6 @ @ @   `c_ж_ж$?C  MORTAL0TE d  6 @ @ @^B  6D?CST ^B  6D?CJK ?2   fXc_ж_ж$? Y  7761/623 %8D d0d  6 @ @ @M2   fc_ж_ж$? Y 3-5 milyon 250-500 bin %10Bd0d 6 @ @ @  BXc_ж_ж ?  )http://www.who.int/csr/media/sars_wha.pdf"*0d*6 @ @ @/   Hc_ж_ж ?w ;http://www.who.int/vaccine_research/documents/new_vaccines "<0d<6 @ @ @<   c $޽h ? ̙33A9___PPT10.]0G+D' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-o6Bdissolve*<3<*D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-o6Bdissolve*<3<*D+' =%(D' =%(D{' =4@BBB B%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =-6B+checkerboard(across)*<3<*D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*+.  0L0 % PHp(  N2   fxc_ж_ж$?B  2NEDEN GR0P A^ISI NEML0 ?,d(B6 @ @ @^  6A ?S<  c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++  0L0 %  (   ^  6A ?'Y<  c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++|&  0L0 % RJ $(  $ $ ZPc_ж_ж ?x `  O J6 @ @ @^ $ 6A ?k ^ $ 6A  ?$ x^ $ 6A  ?:C ^ $ 6A  ?6 qR^ $ 6A  ?` ^ $ 6A  ?6 -]^ $ 6A ? p);<  $ c $޽h ? ̙33!!___PPT10~!.]0G+DR!' = @B D !' = @BA?%,( < +O%,( < +D' =%(D*' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =+4 8?RCBBCB#ppt_wB*Y3>B ppt_w<*$D' =+4 8?RCBBCB#ppt_hB*Y3>B ppt_h<*$D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =-o6Bdissolve*<3<*$D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =-o6Bdissolve*<3<*$D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =-o6Bdissolve*<3<*$D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*$D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*$D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*$D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*$D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*$D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*$D' =%(DF' =%(D' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*$%(D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*$D' =+4 8?dCB1+#ppt_h/2BCB#ppt_yB*Y3>B ppt_y<*$+2  0L0 % TL((  ( ( ZJO_ж_ж ? `}  O J6 @ @ @^ ( 6A ?M ^ ( 6A ?(I< ( c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++2  0L0 % TL,(  , , ZWO_ж_ж ? `}  O J6 @ @ @^ , 6A ?% ^ , 6A ? g< , c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++  0L0 % 0(  0 0 ZcO_ж_ж ?x `  O J6 @ @ @^ 0 6A ?J:i< 0 c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++    0L0 % 4z(  4 4 ZpqO_ж_ж ? `  O J6 @ @ @ 4  Z{O_ж_ж ?   O F2 >~> ~ >~^ 4 6A ?p `C< 4 c $޽h ? ̙33vn___PPT10N.]0G+D"' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*4,%(D' =-o6Bdissolve*<3<*4,D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*4%(D' =-o6Bdissolve*<3<*4+   0L0 % 8(  8 8  ZO_ж_ж ?  `}  O J6 @ @ @^ 8 6A ?/'a< 8 c $޽h ? ̙33{s___PPT10S.]0G+D'' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(Di' =4@BBBB%()))D' =1:Bvisible*o3>+B#style.visibility<*8%(D' =-u6Bdiamond(in)*<3<*8+$  0L0 % <*(  < <  Z_ж_ж ? X  O J6 @ @ @ < <_ж_ж ?'g5 Trler aras1 transfer Antijenik drift Reassortment (Yeniden dzenlenme) ve antijenik shift K1sa sren immuniteZL0nFd0nFd0nFdq 4 >~> ~ >~< < c $޽h ? ̙33p h ___PPT10H .]0G+D ' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*<%(D' =-o6Bdissolve*<3<*<D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*<&%(D' =-o6Bdissolve*<3<*<&Dd' =%(D ' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*<&L%(D' =-o6Bdissolve*<3<*<&LDV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*<L]%(D' =-o6Bdissolve*<3<*<L]D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*<]q%(D' =-o6Bdissolve*<3<*<]qDx' =%(D ' =%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*<&D' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*<&D' =1:Bhidden*o3>+B#style.visibility<*<&%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*<&LD' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*<&LD' =1:Bhidden*o3>+B#style.visibility<*<&L%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*<L]D' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*<L]D' =1:Bhidden*o3>+B#style.visibility<*<L]%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*<]qD' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*<]qD' =1:Bhidden*o3>+B#style.visibility<*<]q%(+   0L0 % @(  @ @  Z _ж_ж ? 9   J6 @ @ @^ @ 6A ?df< @ c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++   0L0 % D(  D D  Z ^_ж_ж ? x `   J6 @ @ @^ D 6A ?/ < D c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++  0L0 % ! H(  H H  Z8_ж_ж ?  `}   J6 @ @ @ H B<_ж_ж ?&pH Influenzavirus A$0 d6 @ @ @ H BH_ж_ж ? h  Influenzavirus B$0 d6 @ @ @ H B[_ж_ж ?P hr Influenzavirus C$0 d6 @ @ @ H Bh]_ж_ж ?  } B {insan d6 @ @ @ H Bj_ж_ж ?0 } R xat d6 @ @ @ H BTh_ж_ж ? $   {domuz d6 @ @ @ H Bp_ж_ж ?0 R   ku_lar d6 @ @ @  H B(_ж_ж ? 2  deniz memelileri d6 @ @ @  H BH_ж_ж ?  {insan d6 @ @ @  H B_ж_ж ?` L >  {insan d6 @ @ @^B  H 6D? ^B  H 6D? ^B H 6D?P p^B H 6D?P ^B H 6D?  ^B H 6D?` P ^B H 6D? H Bش_ж_ж ?: 2 {domuz d6 @ @ @< H c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++  0L0 % 0L(  L L  Z_ж_ж ? + `   J6 @ @ @^ L 6A ?7*< L c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++D  0L0 % f^@P(  P P  ZLל ? Q `    P  Zל ? `  ^ P 6A ?q< P c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++J  0L0 % PT*(  T T  Z@b_ж_ж ? X   J6 @ @ @ T <<_ж_ж ?'g5 Trler aras1 transfer Antijenik drift Reassortment (Yeniden dzenlenme) ve antijenik shift K1sa sren immuniteZL0nFd0nFd0nFdq 4 >~> ~ >~< T c $޽h ? ̙3380___PPT10.]0G+D' = @B D' = @BA?%,( < +O%,( < +D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*T%(D' =-o6Bdissolve*<3<*TD' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*T&%(D' =-o6Bdissolve*<3<*T&Dd' =%(D ' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*T&L%(D' =-o6Bdissolve*<3<*T&LDV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*TL]%(D' =-o6Bdissolve*<3<*TL]D' =%(D' =%(DV' ='@BB B%()))D' =1:Bvisible*o3>+B#style.visibility<*T]q%(D' =-o6Bdissolve*<3<*T]qD' =%(DD' =%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*T]qD' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*T]qD' =1:Bhidden*o3>+B#style.visibility<*T]q%(D' =%(DD' =%(D' =4@BBBB%()))D' =+4 8?\CB#ppt_xBCB#ppt_xB*Y3>B ppt_x<*TD' =+4 8?dCB#ppt_yBCB1+#ppt_h/2B*Y3>B ppt_y<*TD' =1:Bhidden*o3>+B#style.visibility<*T%(+  0L0 % '`X(  X X  Z_ж_ж ? 9   J6 @ @ @^ X 6A ?T1 X Hx_ж_ж ?3 ;www.glycoforum.gr.jp/.../word/ glycopathology/GD-A06E.html $<d:6 @ @ @< X c $޽h ? ̙33ZR___PPT102.]0G+D' = @B D' = @BA?%,( < +O%,( < ++  0L0 %  p\(  \ \  Z_ж_ж ?  `}   J6 @ @ @^ \ 6A ?a \ BxI_ж_ж ?^  0nsan influenzad6 @ @ @ \ B?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{}~`   J6 @ @ @ 8 o `or2 ` B3$?g`'vl ` <$?wWl ` <$?wl ` <$?wHl ` <$?ywl ` <$?w9l  ` <$?jwl  ` <$?w*l  ` <$?\wr2  ` B$?r2  ` B$?%pr2 ` B$?r2 ` B$?S`B `B 0D$?%`B ` 0D$? !`B ` 0D$?u'`B ` 0D$?fB ` 6DWy?WfB ` 6DWy?&/fB `B 6DWy?f fB ` 6DWy?2z 8 P `Pr2 ` B3$?7 l ` <$?0 Gv l ` <$? G l ` <$?! Gg l ` <$? G l ` <$? GY l ` <$? G l  ` <$? GJ l !` <$?| G r2 "` B$?Q